Dr. Sawyers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
Memorial Sloan-Kettering Cancer Center, Box 20
New York, NY 10021Phone+1 646-888-2138- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
University of California (San Francisco)Residency, Internal Medicine, 1985 - 1988
Johns Hopkins University School of MedicineClass of 1985
Certifications & Licensure
NY State Medical License 2006 - 2023
CA State Medical License 1986 - Present- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2008
- Elected Member The American Society for Clinical Investigation, 1999
- Investigator Howard Hughes Medical Institute
Clinical Trials
- BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate Start of enrollment: 2003 Nov 01
- Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse Start of enrollment: 2003 Aug 01
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate Start of enrollment: 2004 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Prospective Clinical Genomic Profiling of Ewing Sarcoma:andMutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance.Koichi Ogura, Arielle Elkrief, Anita S Bowman, Richard P Koche, Elisa de Stanchina, Ryma Benayed, Audrey Mauguen, Marissa S Mattar, Inna Khodos, Paul A Meyers, John H ...> ;JCO precision oncology. 2022 Aug 1
- Allosteric interactions prime androgen receptor dimerization and activation.Elizabeth V Wasmuth, Arnaud Vanden Broeck, Justin R LaClair, Elizabeth A Hoover, Kayla E Lawrence, Navid Paknejad, Kyrie Pappas, Doreen Matthies, Biran Wang, Weiran Fe...> ;Molecular cell. 2022 Jun 2
- Understanding Drug Sensitivity and Tackling Resistance in Cancer.Jeffrey W Tyner, Franziska Haderk, Anbarasu Kumaraswamy, Linda B Baughn, Brian Van Ness, Song Liu, Himangi Marathe, Joshi J Alumkal, Trever G Bivona, Keith Syson Chan,...> ;Cancer research. 2022 Apr 15
- Join now to see all
Journal Articles
- Strategies to Identify and Target Cells of Origin in Prostate CancerCharles Sawyers, MD, Journal of the National Cancer Institute
Authored Content
- Tumor Copy Number Alteration Burden Is a Pan-Cancer Prognostic Factor Associated with Recurrence and DeathSeptember 2018
Press Mentions
Cancer Drug Investigator to Keynote Research DayMarch 28th, 2017
The Cancer News DailyApril 4th, 2016
STAT’s First-Ever Biomedical Innovation Award Awarded to Dr. Charles Sawyers, Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer CenterNovember 21st, 2019- Join now to see all
Grant Support
- Understanding Resistance To Next Generation AntiandrogensNational Cancer Institute2012
- Translational Research In Oncology Training ProgramNational Cancer Institute2011
- Akt-Independent Pathways Of Phosphoinositide 3-Kinase Dependent TransformationNational Cancer Institute2007–2011
- Mouse Models For Human Prostate CancerNational Cancer Institute2007–2008
- Molecular Biology In Clinical Oncology WorkshopNational Cancer Institute2005–2007
- Mouse Models For Human Prostate CancerNational Cancer Institute2000–2006
- Phase I Trial Of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-Aag, NSC #330National Center For Research Resources2005
- Phase I Trial Of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-Aag, NSC #330...National Center For Research Resources2004
- Targeted Therapy Of PTEN NULL Prostate CancerNational Cancer Institute2002
- Regulation Of The PTEN Tumor Suppressor Gene In Prostate CancerNational Cancer Institute2002
- Imaging Prostate Cancer Bone MetastasisNational Cancer Institute2000–2002
- Regulation Of The PTEN Gene In Prostate CancerNational Cancer Institute2000–2001
- Stem Cell Genes In Prostate Growth And DifferentiationNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2001
- Role Of C-Able Nuclear Tyrosine Kinase In Normal And Malignant Cell GrowthNational Cancer Institute1995–2000
- Mouse Models For Prostate CancerNational Cancer Institute1999
- P53 In Chronic Myelogenous LeukemiaNational Cancer Institute1990–1994
Hospital Affiliations
Memorial Sloan-Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
